共 50 条
- [41] Bimekizumab safe and effective for AS and PsA in long-term trials Nature Reviews Rheumatology, 2022, 18 : 494 - 494
- [43] Long-term and preventive effects of sublingual allergen-specific immunotherapy: A retrospective, multicentric study INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (01): : 73 - 79
- [48] A Long-Term Follow-up Study of Asthmatic Children Discontinued Allergen-Specific Immunotherapy JOURNAL OF CHILD SCIENCE, 2024, 14 (01): : e19 - e23